The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
Open accessAbstract
The anti-diabetic drug metformin targets pancreatic cancer stem cells (CSCs), but not their differentiated progenies (non-CSCs), which may be related to distinct metabolic phenotypes. Here we conclusively demonstrate that while non-CSCs were highly glycolytic, CSCs were dependent on oxidative metabolism (OXPHOS) with very limited metabolic plasticity. Thus, mitochondrial inhibition, e.g., by metformin, translated into energy crisis and apoptosis. However, resistant CSC clones eventually emerged during treatment with metformin due to their intermediate glycolytic/respiratory phenotype. Mechanistically, suppression of MYC and subsequent increase of PGC-1α were identified as key determinants for the OXPHOS dependency of CSCs, which was abolished in resistant CSC clones. Intriguingly, no resistance was observed for the mitochondrial ROS inducer menadione and resistance could also be prevented/reversed for metformin by genetic/pharmacological inhibition of MYC. Thus, the specific metabolic features of pancreatic CSCs are amendable to therapeutic intervention and could provide the basis for developing more effective therapies to combat this lethal cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“High glycolytic flux is required to maintain upregulated PGD metabolism, and this in maintained in part through suppression of thioredoxin-interacting protein (TXNIP) transcription243.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [243]
Citations
Cites
Trapnell, C., Roberts, A., Goff, L. A., Pertea, G. M., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. S. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,145
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P. D., Burant, C., Zhang, L., Adsay, V. N., Wicha, M. S., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,419
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M. O., Bruns, C. J., & Heeschen, C. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,946
Self-citationHidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Lagadinou, E. D., Sach, A., Callahan, K. P., Rossi, R. M., Neering, S. J., Minhajuddin, M., Ashton, J. M., Pei, S., Grose, V., O’Dwyer, K. M., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2012.12.013 · Cited by 1,465
LeBleu, V. S., O’Connell, J. T., Herrera, K. N. G., Wikman, H., Pantel, K., Haigis, M. C., de Carvalho, F. M., Damascena, A. S., Chinen, L. T. D., Rocha, R. M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3039 · Cited by 1,438
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 727
The Warburg effect on radioresistance: Survival beyond growth
Kang, H., Kim, B., Park, J., Youn, H., & Youn, B. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188988 · Cited by 67
Sun, X., Johnson, J. L., & John, J. C. S. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky339 · Cited by 62
Raninga, P. V., Lee, A., Sinha, D., Dong, L., Datta, K. K., Lu, X. M., Croft, P. K., Dutt, M., Hill, M. M. C., Pouliot, N., et al. (2020) · Theranostics · doi:10.7150/thno.42705 · Cited by 62
Nutritional Exchanges Within Tumor Microenvironment: Impact for Cancer Aggressiveness
Comito, G., Ippolito, L., Chiarugi, P., & Cirri, P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00396 · Cited by 60
Feng, J., Lian, Z., Xia, X., Lu, Y., Hu, K., Zhang, Y., Liu, Y., Hu, L., Yuan, K., Sun, Z., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.10.023 · Cited by 63
Qiu, X., Li, Y., & Zhang, Z. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00801-0 · Cited by 69
Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I
Ling, S., Shan, Q., Liu, P., Feng, T., Zhang, X., Xiang, P., Chen, K., Xie, H., Song, P., Zhou, L., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.482 · Cited by 61
Mechanisms of venetoclax resistance and solutions
Liu, J., Chen, Y., Yu, L., & Yang, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1005659 · Cited by 60
Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy
Rouzbahani, E., Majidpoor, J., Najafi, S., & Mortezaee, K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113906 · Cited by 62
The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance
Patil, K., Badrealam, K. F., Akhtar, S., Ahmad, A., & Shahab Uddin, M. S. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09979-x · Cited by 60
Mitochondrial Redox Hubs as Promising Targets for Anticancer Therapy
Ippolito, L., Giannoni, E., Chiarugi, P., & Parri, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00256 · Cited by 60
Energy metabolism in cancer stem cells
Zhu, X., Chen, H., Gao, C., Zhang, X., Jiang, J., Zhang, Y., Fang, J., Zhao, F., & Chen, Z. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i6.448 · Cited by 62
The Metabolic Heterogeneity and Flexibility of Cancer Stem Cells
Tanabe, A., & Sahara, H. (2020) · Cancers · doi:10.3390/cancers12102780 · Cited by 61
Courtois, S., de Luxán‐Delgado, B., Penin-Peyta, L., Royo-García, A., Parejo-Alonso, B., Jagušt, P., Alcalá, S., Rubiolo, J. A., Sanchez, L. E., Sáinz, B., et al. (2021) · Cancers · doi:10.3390/cancers13040698 · Cited by 60
Self-citationZheng, X., Yu, C., & Xu, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.678333 · Cited by 63
Jain, A., & Bhardwaj, V. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i39.6527 · Cited by 64
Cell line-directed breast cancer research based on glucose metabolism status
Farhadi, P., Yarani, R., Valipour, E., Kiani, S., Hoseinkhani, Z., & Mansouri, K. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112526 · Cited by 60
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
Fu, Y., Ricciardiello, F., Yang, G., Qiu, J., Huang, H., Xiao, J., Cao, Z., Zhao, F., Liu, Y., Luo, W., et al. (2021) · Cells · doi:10.3390/cells10030497 · Cited by 59
Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy
Papadaki, S., & Magklara, A. (2022) · Cancers · doi:10.3390/cancers14235912 · Cited by 62
Nomura, A., Dauer, P., Gupta, V. K., McGinn, O., Arora, N., Majumdar, K., Uhlrich, C., Dalluge, J. J., Dudeja, V., Saluja, A. K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10838 · Cited by 58
Mitochondrial biology in cancer stem cells
Loureiro, R., Mesquita, K. A., Novais, S. M., Oliveira, P. J., & Vega‐Naredo, I. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.012 · Cited by 63
Qiao, L., Chen, Y., Liang, N., Xie, J. W., Deng, G., Chen, F., Wang, X., Liu, F., Li, Y., & Zhang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.775238 · Cited by 58
Therapeutic Targeting of Cancer Stem Cells: Integrating and Exploiting the Acidic Niche
Linden, C. V., & Corbet, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00159 · Cited by 58
Metabolism and epigenetics of pancreatic cancer stem cells
Lanfranca, M. P., Thompson, J. K., Bednar, F., Halbrook, C. J., Lyssiotis, C. A., Lévi, B., & Frankel, T. L. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.09.008 · Cited by 58
You, R., Wang, B., Chen, P., Zheng, X., Hou, D., Wang, X., Zhang, B., Chen, L., Li, D., Lin, X., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215582 · Cited by 56
The role of tumor microenvironment on cancer stem cell fate in solid tumors
Razi, S., Haghparast, A., Khameneh, S. C., Sadrabadi, A. E., Aziziyan, F., Bakhtiyari, M., Nabi‐Afjadi, M., Tarhriz, V., Jalili, A., & Zalpoor, H. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01129-w · Cited by 56
Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence
Vessoni, A. T., Filippi‐Chiela, E. C., Lenz, G., & Batista, L. F. Z. (2019) · Oncogene · doi:10.1038/s41388-019-1128-4 · Cited by 59
Phytochemicals regulate cancer metabolism through modulation of the AMPK/PGC-1α signaling pathway
Fakhri, S., Moradi, S. Z., Moradi, S. Y., Piri, S., Varnamkhasti, B. S., Piri, S., Khirehgesh, M. R., Bishayee, A., Casarcia, N., & Bishayee, A. (2024) · BMC Cancer · doi:10.1186/s12885-024-12715-7 · Cited by 57
Zhao, H., Chang, Y., Hu, Y., Mu, L., Liu, S., Huang, K., Li, Q., Li, X., Tao, D., & Qin, J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.08.044 · Cited by 57
Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death
Läsche, M., Emons, G., & Gründker, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00409 · Cited by 55
Payandeh, Z., Tazehkand, A. P., Barati, G., Pouremamali, F., Kahroba, H., Baradaran, B., & Samadi, N. (2020) · Biochimie · doi:10.1016/j.biochi.2020.09.014 · Cited by 54
Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells
Chen, W.-C., To, M. D., Westcott, P. M. K., Delrosario, R., Kim, I.-J., Philips, M. R., Tran, Q., Bollam, S., Goodarzi, H., Bayani, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24498-7 · Cited by 64
Current and upcoming mitochondrial targets for cancer therapy
Kim, H. K., Noh, Y. H., Nilius, B., Ko, K. S., Rhee, B. D., Kim, N., & Han, J. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.006 · Cited by 52
Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations
Chan, M. M.-Y., Chen, R., & Fong, D. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.06.034 · Cited by 53
Ervin, E.-H., French, R., Chang, C., & Pauklin, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.11.001 · Cited by 53
Targeting Cell Metabolism as Cancer Therapy
Ngoi, N. Y. L., Eu, J. Q., Hirpara, J. L., Wang, L., Lim, J. S. J., Lee, S. C., Lim, Y., Pervaiz, S., Goh, B. C., & Wong, A. L. A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7947 · Cited by 52
Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast Cancer
El‐Sahli, S., & Wang, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239125 · Cited by 52
Egan, G., Khan, D. H., Lee, J. B., Mirali, S., Zhang, L., & Schimmer, A. D. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1227 · Cited by 52
Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics
健次, 平., & Wang, H. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1125174 · Cited by 53
Dai, J., Ji, Y., Wang, W., Kim, D., Yenwongfai, L. N., Wang, L., Luo, J., & Zhang, Z. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.06.014 · Cited by 51
Reprogramming to developmental plasticity in cancer stem cells
O’Brien‐Ball, C., & Biddle, A. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.07.025 · Cited by 51
Targeting of stress response pathways in the prevention and treatment of cancer
Zelenka, J., Koncošová, M., & Ruml, T. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.01.007 · Cited by 50
HDAC2 Facilitates Pancreatic Cancer Metastasis
Krauß, L., Urban, B. C., Hastreiter, S., Schneider, C., Wenzel, P., Hassan, Z., Wirth, M., Lankes, K., Terrasi, A., Klement, C., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3209 · Cited by 49
Overcoming treatment resistance in cancer: Current understanding and tactics
Wu, G. J., Wilson, G., George, J., Liddle, C., Hebbard, L., & Qiao, L. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.018 · Cited by 49
p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer
Chang, H. W., Kim, M. R., Lee, H. J., Lee, H. M., Kim, G. C., Lee, Y. S., Nam, H. Y., Lee, M., Jang, H. J., Lee, K. E., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0697-6 · Cited by 48
Metabolic Plasticity in Ovarian Cancer Stem Cells
Ghoneum, A., Gonzalez, D., Abdulfattah, A. Y., & Said, N. A. (2020) · Cancers · doi:10.3390/cancers12051267 · Cited by 47
CIP2A induces PKM2 tetramer formation and oxidative phosphorylation in non-small cell lung cancer
Liang, L.-J., Yang, F., Wang, D., Zhang, Y., Yu, H., Wang, Z., Sun, B., Liu, Y., Wang, G., & Zhou, G. (2024) · Cell Discovery · doi:10.1038/s41421-023-00633-0 · Cited by 47
Karlstaedt, A., Barrett, M., Hu, R., Gammon, S. T., & Ky, B. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.05.008 · Cited by 48
Yu, M., Pan, Q., Li, W., Du, T., Huang, F., Wu, H., He, Y., Wu, X., & Shi, H. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155045 · Cited by 47
PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness
Kaminski, L., Torrino, S., Dufies, M., Djabari, Z., Haider, R., Roustan, F., Jaune, E., Laurent, K., Nottet, N., Michiels, J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2043 · Cited by 46
Li, Y., Luo, J., Lin, M., Zhi, P., Guo, W.-W., Han, M. Y., You, J., & Gao, J. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00199 · Cited by 45
Circumventing senescence is associated with stem cell properties and metformin sensitivity
Deschênes‐Simard, X., Parisotto, M., Rowell, M., Le Calvé, B., Igelmann, S., Moineau‐Vallée, K., Saint‐Germain, E., Kalegari, P., Bourdeau, V., Kottakis, F., et al. (2019) · Aging Cell · doi:10.1111/acel.12889 · Cited by 45
Metabolic regulation of glioma stem-like cells in the tumor micro-environment
Thomas, T. M., & Yu, J. S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.014 · Cited by 48
Charpentier, J., Briand, F., Lelouvier, B., Servant, F., Azalbert, V., Puel, A., Christensen, J. E., Waget, A., Branchereau, M., Garret, C., et al. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01657-8 · Cited by 47
Praharaj, P. P., Patro, B. S., & Bhutia, S. K. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15401 · Cited by 44
Crosstalk between autophagy and CSCs: molecular mechanisms and translational implications
Dai, L., Peng, X., He, G., Liu, J., Li, X., Lin, W., Fang, J., Li, X., Yang, S., Yang, L., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05929-3 · Cited by 46
He, B., Gao, R., Lv, S., Chen, A., Huang, J., Wang, L., Feng, Y., Feng, J., Liu, B., Lei, J., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01487-4 · Cited by 43
Metabolism and Transcription in Cancer: Merging Two Classic Tales
Martín-Martín, N., Carracedo, A., & Torrano, V. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00119 · Cited by 43
Paskeh, M. D. A., Asadi, S., Zabolian, A., Saleki, H., Khoshbakht, M. A., Sabet, S., Naghdi, M. J., Hashemi, M., Hushmandi, K., Ashrafizadeh, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111669 · Cited by 43
Current status of mathematical modeling of cancer – From the viewpoint of cancer hallmarks
Magi, S., Iwamoto, K., & Okada, M. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.02.008 · Cited by 43
Banerjee, A., Birts, C. N., Darley, M., Parker, R., Mirnezami, A. H., West, J. J., Cutress, R., Beers, S. A., Rose-Zerilli, M. J. J., & Blaydes, J. P. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy174 · Cited by 44
Shoshan‐Barmatz, V., Anand, U., Crystal, E. N., Carlo, M. D., & Shteinfer‐Kuzmine, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.730048 · Cited by 42
Cancer stem cells: a target for overcoming therapeutic resistance and relapse
Zhang, S., Yang, R., Ouyang, Y., Shen, Y., Hu, L., & Xu, C. S. (2024) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0333 · Cited by 45
Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy
Alcalá, S., Villarino, L., Ruíz-Cañas, L., Couceiro, J. R., Martínez‐Calvo, M., Palencia‐Campos, A., Navarro, D., Cabezas‐Sainz, P., Rodríguez-Arabaolaza, I., Barreal, A. C., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02931-7 · Cited by 40
The Metabolic Landscape of Cancer Stem Cells: Insights and Implications for Therapy
Milella, M., Rutigliano, M., Pandolfo, S. D., Aveta, A., Crocetto, F., Ferro, M., d’Amati, A., Ditonno, P., Lucarelli, G. T., & Lasorsa, F. M. (2025) · Cells · doi:10.3390/cells14100717 · Cited by 46
How does metabolism affect cell death in cancer?
Villa, E., & Ricci, J. (2015) · FEBS Journal · doi:10.1111/febs.13570 · Cited by 42
Petrachi, T., Romagnani, A., Albini, A., Longo, C., Argenziano, G., Grisendi, G., Dominici, M., Ciarrocchi, A., & Dallaglio, K. (2016) · Oncotarget · doi:10.18632/oncotarget.14321 · Cited by 41
Bioactive lipids in cancer stem cells
Begicevic, R.-R., Arfuso, F., & Falasca, M. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i9.693 · Cited by 41
Metformin: Metabolic Rewiring Faces Tumor Heterogeneity
Cioce, M., Pulito, C., Strano, S., Blandino, G., & Fazio, V. M. (2020) · Cells · doi:10.3390/cells9112439 · Cited by 41
Conflicting metabolic alterations in cancer stem cells and regulation by the stromal niche
Yasuda, T., Ishimoto, T., & Baba, H. (2021) · Regenerative Therapy · doi:10.1016/j.reth.2021.01.005 · Cited by 42
Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies
Mancini, S. J. C., Balabanian, K., Corre, I., Gavard, J., Lazennec, G., Bousse‐Kerdilès, M. L., Louache, F., Maguer‐Satta, V., Mazure, N. M., Mechta‐Grigoriou, F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.766275 · Cited by 41
Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress
Tang, Y., Zhang, Z., Chen, Y., Qin, S., Zhou, L., Gao, W., & Shen, Z. (2022) · Antioxidants · doi:10.3390/antiox11071324 · Cited by 47
Phytochemicals Target Multiple Metabolic Pathways in Cancer
Shuvalov, O. Y., Kirdeeva, Y., Daks, A. A., Fedorova, O., Parfenyev, S. E., Simon, H., & Barlev, N. A. (2023) · Antioxidants · doi:10.3390/antiox12112012 · Cited by 43
The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities
Cordani, M., Michetti, F., Zarrabi, A., Zarepour, A., Rumio, C., Strippoli, R., & Marcucci, F. (2024) · Neoplasia · doi:10.1016/j.neo.2024.101076 · Cited by 40
Yu, X. M., Fang, B., Liu, Y., Yan, S., Cao, D., Mei, H., Wang, Q., Hu, Y., & Guo, T. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117971 · Cited by 40
Chaudhary, S., Ganguly, S., Palanichamy, J. K., Singh, A., Bakhshi, R., Jain, A., Chopra, A., & Bakhshi, S. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.03.013 · Cited by 43
Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?
Banz‐Jansen, C., Helweg, L. P., & Kaltschmidt, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063412 · Cited by 41
Perkhofer, L., Walter, K., Costa, I. G., Carrasco, M. C. R., Eiseler, T., Hafner, S., Genze, F., Zenke, M., Bergmann, W., Illing, A., et al. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.08.007 · Cited by 39
Sniping Cancer Stem Cells with Nanomaterials
Wang, W.-D., Guo, Y., Yang, Z., Su, G.-L., & Sun, Z. (2023) · ACS Nano · doi:10.1021/acsnano.3c07828 · Cited by 38
Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.09.001 · Cited by 39
Ózsvári, B., Fiorillo, M., Bonuccelli, G., Cappello, A. R., Frattaruolo, L., Sotgia, F., Trowbridge, R., Foster, R., & Lisanti, M. P. (2017) · Oncotarget · doi:10.18632/oncotarget.19084 · Cited by 42
Stem Cell Metabolism in Cancer and Healthy Tissues: Pyruvate in the Limelight
Corbet, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00958 · Cited by 39
Deciphering the Dichotomous Effects of PGC-1α on Tumorigenesis and Metastasis
Gravel, S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00075 · Cited by 41
Bigelsen, S. (2018) · Cancer Management and Research · doi:10.2147/cmar.s161824 · Cited by 39
The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma
Lin, S., Huang, C., Sun, J., Bollt, O., Wang, X., Martine, E., Kang, J., Taylor, M. D., Fang, B., Singh, P. K., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910849 · Cited by 38
Metabolic Regulation of Epithelial to Mesenchymal Transition: Implications for Endocrine Cancer
Bhattacharya, D., & Scimè, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00773 · Cited by 39
Kim, J., & Cheong, J. (2020) · Cells · doi:10.3390/cells9071691 · Cited by 40
Hassan, S., Blick, T., Thompson, E. W., & Williams, E. D. (2021) · Cancers · doi:10.3390/cancers13112750 · Cited by 38
Cancer—A Major Cardiac Comorbidity With Implications on Cardiovascular Metabolism
Finke, D., Heckmann, M. B., Frey, N., & Lehmann, L. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.729713 · Cited by 40
Energy sources identify metabolic phenotypes in pancreatic cancer
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw097 · Cited by 37
BICC1 drives pancreatic cancer stemness and chemoresistance by facilitating tryptophan metabolism
Sun, H., Li, H., Guan, Y., Yuan, Y., Xu, C., Fu, D., Xie, P., Li, J., Zhao, T., Wang, X., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj8650 · Cited by 38
Mascaraque, M., Courtois, S., Royo-García, A., Barneda, D., Stoian, A. M., Villaoslada, I., Espiau-Romera, P., Bokil, A. A., Cano-Galiano, A., Jagušt, P., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05598-6 · Cited by 39
Self-citationMolecular and Metabolic Subtypes Correspondence for Pancreatic Ductal Adenocarcinoma Classification
Espiau-Romera, P., Courtois, S., Parejo-Alonso, B., & Sancho, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124128 · Cited by 43
Self-citationLee, A. C. K., Lau, P. M., Kwan, Y. W., & Kong, S. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073315 · Cited by 39
Sumithion usage in aquaculture: benefit or forfeit?
Shahjahan, M., Islam, S. M., Bablee, A. L., Siddik, M. A. B., & Fotedar, R. K. (2021) · Reviews in Aquaculture · doi:10.1111/raq.12560 · Cited by 38
Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy
Kaur, J., & Bhattacharyya, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.756888 · Cited by 38
Metabolic plasticity of cancer stem cells
Luo, M., & Wicha, M. S. (2015) · Oncotarget · doi:10.18632/oncotarget.6177 · Cited by 38
The biological role of metabolic reprogramming in pancreatic cancer
Suzuki, T., Otsuka, M., Seimiya, T., Iwata, T., Kishikawa, T., & Koike, K. (2020) · MedComm · doi:10.1002/mco2.37 · Cited by 38
Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma
Bubin, R., Uljanovs, R., & Štrumfa, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087030 · Cited by 39
Deng, J., Pan, T., Lv, C., Cao, L., Li, L., Zhou, X., Li, G., Li, H., Vicencio, J. M., Xu, Y., et al. (2023) · Theranostics · doi:10.7150/thno.84937 · Cited by 37
Metadata
- Authors
- Sancho, P., Burgos-Ramos, E., Tavera, A., Bou Kheir, T., Jagust, P., Schoenhals, M., Barneda, D., Sellers, K., Campos-Olivas, R., Graña, O., Viera, C. R., Yuneva, M., Sainz, B., & Heeschen, C.
- Affiliations
- Queen Mary University of London (GB)
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Sancho, Patricia
- Heeschen, Christopher
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 22
- Issue
- 4
- Pages
- 590-605
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W1892036645
- Cited by
- 722
- References
- 44
- Citations by year
- 2026: 36 · 2025: 51 · 2024: 60 · 2023: 72 · 2022: 79 · 2021: 88 · 2020: 94 · 2019: 79 · 2018: 65 · 2017: 51 · 2016: 41 · 2015: 5
- FWCI
- 17.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- RUIdeRA - Institutional University Repository (University of Castilla-La Mancha) (submittedVersion, other-oa)
- Funders
- Francis Crick Institute (10223)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic cancer stem cells, c-Myc, PGC-1α, metformin, oxidative phosphorylation, glycolysis, metabolic plasticity, drug resistance, mitochondrial reactive oxygen species, menadione, apoptosis, energy crisis, cancer metabolism
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, AC133 Antigen, Animals, Antineoplastic Agents, Glycoproteins, Humans, Metformin, Mice, Nude, Mitochondria, Oxidative Phosphorylation, Pancreatic Neoplasms, Peptides, Phenotype, Transcription Factors, Tumor Cells, Cultured, Neoplastic Stem Cells, Antigens, CD, Gene Library, Proto-Oncogene Proteins c-myc, Reactive Oxygen Species, Drug Resistance, Neoplasm, Vitamin K 3, RNA Interference, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
